Antieosinophil Antibodies Alone or in Combination with Antineutrophil Cytoplasmic Antibodies (ANCA) Detected in Different Autoimmune Conditions

Table 1

Clinical and laboratory characteristics of AEOSA+/ANCA+ and AEOSA+/ANCA− patients.

	AEOSA+/ANCA+ (n = 16)	AEOSA+/ANCA− (n = 20)	p-values
Age, years ± SD	59 ± 18	55 ± 17	0.3725
Female, n (%)	12 of 16 (75)	13 of 20 (65)	0.8125
TPO positive, n (%)	6 of 15 (40)	2 of 18 (11)	0.1015
TG positive, n (%)	2 of 5 (40)	1 of 7 (14)	0.5227
SMA positive, n (%)	2 of 12 (17)	2 of 18 (11)	0.9999
Parietal cell antibody positive, n (%)	4 of 12 (33)	0 of 18 (0)	0.0181
Diagnosis of liver disease, n (%)	1 of 16 (6)	5 of 20 (25)	0.1962
Diagnosis of thyroid disease, n (%)	7 of 16 (44)	2 of 20 (10)	0.0491
Diagnosis of vasculitides, n (%)	6 of 16 (38)	1 of 20 (5)	0.0298

Abbreviations: TPO, thyroid peroxidase; TG, thyroglobulin; SMA, smooth muscle antibody. Significant p-values have been highlighted in bold.